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4-Hydroxynonenal (4-HNE) is a major propagation product of lipid peroxidation that is supposed to be responsible for some of 
the effects associated with oxidative stress in tissues. We have investigated the possible occurrence and distribution of 
4-HNE-immunoreactivity in human normal placenta using immunocvtochemistrv. Specific immunostaining was observed in 
cytotrophoblast cells, syncytiotrophoblast, ome cells of the villous mesenchyme and somc endothelial cells of first t,'imester and 
term placentae. The detection of 4-HNE-immunoreactivitv in placenta raises the question whether lipoperoxidation products are 
produced localh' in placental cells or represent exogenous products that derive fi'om maternal blood flow. Since trophnblastic cells 
and villous macrophages are provided by a scavenger receptor, it is conceivable that these cells may play a protective role with 
regard to the diffusion of lipoperoxidation products from the mother to the embryo. However, since a significant degree of lipid 
oxidative modification does not take place in plasma, it is presumed that 4-HNE is a local product of placental metabolism. In line 
with this hypothesis, it is proposed that maternal low density lipoproteins, which are the major source of cholesterol for placental 
steroid synthesis, might be oxidized by villous cells during their traversal through the villous wall. 
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INTRODUCTION 
Human placental cells interact with all of the major classes of 
normal circulating lipoproteins, and lipoprotuin mctabolism is 
related to fetal growth and development (Knopp ct al., 1985, 
19911. Recently, scavenger receptor activity has been demon- 
stratcd in placental cells in vitro, thus suggesting that placenta 
may bind and metabolize also modified lipoprotcins (Malassind 
ct al., 1990; Bonet et al., 1995). There is also evidence that 
lipoprotein oxidation may be enhanced in pregnancy (Ishihara, 
1978; Hubel et al., 1989) and it has been presumed reasonabh, 
that normal lipoproteins might be oxidized by trophoblast cells 
(Bonet et al., 19951. 
Polyunsaturated t:attv acids (PUFA), major components of 
all circulating lipoproteins, are amongst he most susceptible 
molecules to oxidative stimuli within the cell. During the 
oxidative degradation of PUFA, a variety of reactive aldehvdic 
products--including 4-hvdroxvnonenal (4-HNE) and 
malondialdehyde--are formed. These products are capable of 
attaching covalently to protein, particularly to the upsilon 
amino groups of h'sinu residues, thus producing important 
biological actions (for a review see Estubauer, Schaur and 
Zollner, 1991). Because of its stability, 4-HNE, as a major 
propagation product of lipid peroxidation, represents a suitable 
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epitope to reveal the situs of lipid peroxidation using 
immunochcnfical methods (Yla-Herttuala et al., 1989; Palinski 
et al., 1990; Rosenfeld et al., 1990). 
The aim of our study was to investigate the possible 
occurrence and distribution of 4-HNE-immunoruactivitv in 
human normal placenta using immunohistochemistrv. 
MATERIALS  AND METHODS 
Sample  co l lec t ion  and preparat ion 
First trimester human placentae (n=13) were collected fi'om 
legal abortions at 8-12 weeks of pregnancy. Reasons for 
interruptions were unlikely to affect placental fimction and 
structure. Full-term placentae (11=23) were obtained from 
vaginal delivery after uncomplicated pregnancy. 
Placental tissue was cut into blocks that were immediately 
immersed in a solution of 4 per cent paraformaldehyde (w/v) 
in 0.1 .,M phosphate buffer, pH 7.4 for 0-8 h. To examine 
whether 4-HNE-reactive material was produced during tissue 
fixation and embedding, either 0.9 mmol/I  azide, a myeloper- 
oxidasc inhibitor, or 2(I lumol/1 butvlated hydrox.vtoluene and 
2 nmol/1 EDTA were added to the fixative used for some 
placentae (13oyd et al., 1989; Palinski et al., 1989, 1995; Hazell 
et al., 1996). Alter washing in phosphate buffer, thu specimens 
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were dehydrated through graded concentrations of ethanol, 
embedded in paraffin, and sectioned at 5-10 ~tm. 
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contain -I--HNE-modified lipoproteins (Yla-Herttuala et al., 
1989; Palinski et al., 1990; Rosenfeld et al., 1990), as positive 
control tissue. 
Immunohistochemistry 
Staining protocol. Dewaxed sections were processed for the 
immunohistochemical demonstration of 4-HNE according to 
the indirect biotin-streptavidin mmunoperoxidase t chnique 
(Hsu, Raine and Fangcr, 1981). Briefly, the sections were 
incubated serially with the following solutions: (1) 0.3 per cent 
hydrogen peroxide for 30 min to remove endogenous peroxi- 
dase activity; (2) normal goat serum, diluted 1 : 20, for 30 min 
to reduce non-specific background staining; (3) mouse mono- 
clonal antibodies to 4-HNE, at a range of dilutions (a dilution 
of 1 : 200 with overnight incubation at 4°C was found to be 
optimal); (4) pre-diluted biotinylated goat anti-mouse IgG 
(Super Sensitive kit BioGenex, San Ramon, USA), for 1 h at 
room temperature; (5) pre-diluted streptavidin-biotinylated 
peroxidase complexes (Super Sensitive kit, BioGenex, San 
Ramon, USA), for 1 h at room temperature; (6) 0.03 per cent, 
3,3'diaminobenzidine tetrahydrochloride, to which hydrogen 
peroxide (0.02 per cent) was added just before use, for 5 min at 
room tempcrature. Each solution was prepared in 0.05 M Tris 
buffer, pH 7.4, containing 0.1 tool/1 NaCI (0.15 M Tris- 
buffered saline) and between each step of the immunostaining 
procedure the sections were washed in the same buffer. Some 
sections were lightly counterstained with haematoxylin. The 
sections werc finally dchydratcd, mountcd and observed in 
a Zeiss microscope equipped with Nomarski differential 
interference contrast device. 
4-HNE-an/ibodies am/ spec(fici O, controls of the imnmnohisto- 
chemical reaction. Mouse monoclonal antibodies against 
4-HNE (clones lg4h7 and 1h4h12, subtypes IgG1 k) were 
produccd using 4-hydroxynonenal coupled to bovine serum 
albumin. The epitope recognized by these clones was found to 
be 4-hydroxynonenal bound to hvstidinc. This epitope is 
recognized on any 4-HNE-modified protein so far tested, while 
native proteins do not show cross-reactivity. With regard to 
clone l g4h7, lcss than 1 per cent cross-reactivity exists to 
4-HNE-lvsine or 4-HNE-cvsteine. With regard to clone 
lh4h12, 4-HNE-Ivsine is recognized with about 20 per cent 
cross-reactivity, while 4-HNE-cvsteine shows 2 per cent cross- 
reactivity (data not shown). We have performed specificity 
tests, including adsorption of the antibodies with related and 
unrelated antigens, omission of the first laver and substitution 
of an inappropriate antiserum or a non-immune serum for the 
specific primary antibodies (Polak and Van Noorden, 1986). 
Immunostaining was completely prevented by absorption of 
HNE-antibodies with HNE coupled to albumin, whereas 
native albumin was uneffective in absorbing the antibodies 
(10 nmol in 1 ml antibodies diluted 1 : 200 in tris buffer). 
As a further control of 4-HNE-immunostaining, we have 
used human carotid atherosclerotic lesions, which are known to 
R ES U LTS 
Specific 4-HNE-immunoreactivity was observed in all pla- 
centae examined. The reaction appeared finely granular within 
the cytoplasm of trophoblast cells. In first trimester placentae, 
cytotrophoblast cells displayed stronger immunoreactivity 
compared with syncytiotrophoblast [Figure I(A)]. In term 
placentae, where cytotrophoblast cells are greatly decreased in 
number, positive staining was observed in the syncytium 
[Figure I(B)]. In the villous stroma of both first trimester and 
term placentae, mesenchymal cells and blood vessel endo- 
thelium were occasionally stained (Figure 2). No specific 
staining could be observed in control sections. Inclusion of 
antioxidants during tissue fixation did not result in an 5' 
apparent differences in the staining (data not shown) when 
compared with tissues fixed using the routine procedure, 
indicating that the material recognized by 4-HNE-antibodies 
was not generated uring sample preparation. 
As a positive control of 4-HNE-immunocytochemical reac- 
tion, we revealed also 4-HNE-like immunoreactive material in 
atherosclerotic plaques (data not shown). The immuno- 
reactivity pattern and the tissue distribution observed in our 
samples matched well with those reported in previous 
immunohistochemical studies (Yla-Herttuala et al., 1989; 
Palinski et al., 1990; Rosenfeld et al., 1990). 
DISCUSSION 
This study shows the occurrence and distribution of 4-HNE, 
a major propagation aldehydic product of lipid peroxidation, 
in normal human placenta. To date, the tissue distribution of 
4-HNE and related molecules have been investigated only 
in pathological tissues, nameh, atherosclerotic lesions 
(Haberland, Fong and Cheng, 1988; Boyd et al., 1989; 
Yla-Herttuala et al., 1989; Palinski et al., 1990, 1995; 
Rosenfeld et al., 1990, 1991; Jurgens et al., 1993; Hazell 
et al., 1996). These investigations have provided convincing 
evidence that lipoperoxidation products actually occur in 
atherosclerotic plaques, thus providing further support to the 
hypothesis that oxidized lipoproteins might be involved in 
the pathogenesis of atherosclerosis (for a review see Witzum 
and Steinberg, 1991). 
In general, increasing evidence xists that aldehydes gener- 
ated during the process of lipid peroxidation are responsible 
for some of the effects associated with oxidative stress in cells 
and tissues (for a review see Esterbauer, Schaur and Zollner, 
19915. In fact, unlike reactive free radicals, aldehydes are rather 
long lived and can attack intracellular targets that are distant 
from the initial free radical event. Therefore, it has been 
proposed that 4-hydroxyalkenals, uch as 4-HNE, may be 
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F igure  1. Immunohistochcmical localization of 4~h.vdroxynonenal- 
immunoreactivity in (A) human first trimester and (B) term placentae. 
Immunostaining is detectable in trophoblast layers and some mesench.vmal 
cells of he villous stroma. In first trimester placenta, the reaction is more 
intense in eytotrophoblast cells than in fbrming s.vncytium (A). In term 
placentae, where eytotrophoblast cells are reduced in number, tbe staining 
is visible in the syncytium (B). Indirect immunoperoxidasc method. 
llar=O.O1 mm. 
considered as second toxic messengers of the chain reactions 
that are initiated if polyunsaturated fatty acids are converted in 
lipid hydroperoxides (Esterbauer, Schaur and Zollner, 1991). 
In this connection, it must be considered that hydroxyalkenals 
are highly reactive molecules, that are able to react with SH 
and NH groups contained in aminoacids, proteins and nuclear 
nucleotides. Indeed, an extensive literature xists concerning 
the possible biological effects of hydroxyalkenals in cells and 
tissues. These include: (1) cytotoxicity (due to inhibition of 
DNA, RNA and protein synthesis, disturbance of calcium 
homeostasis, inhibition of respiration and glycolysis; 
Hauptlorenz et al., 1985; Griffin and Segal, 1986; Poot et al., 
1988b); (2) modulation of adenylate cyclase activity and stimu- 
lation of phospholipase C (Dianzani, 1982; Rossi, Garramone 
and Dianzani, 1988; Rossi et al., 1990); (3) induction or 
reduction of gene transcription (such as c-myc; Barrera et al., 
1987; Cajone, Salina and Benelli-Zazzera, 1989); and (4) cell 
251 
• % • 
, ) .  
I t -/ 
F igure  2. In~n~unobistochemical localization of 4-hydroxynonenal- 
immunoreactivity n human normal placenta. Beside trophoblast cells, some 
mescnchvmal cells and endothelial cells . f  the villous stroma (Arrows) display 
positive staining, indirect imnlunnperoxidase m thod. Bar=0.01 ram. 
growth inhibition (through inhibition of DNA polymerase 
s.vstem; Brarnbilla et al., 1986; Wawra et al., 1986; Poot et al., 
1988a,b). 
Although the formation of reactive aldehydes has been 
mostly studied in pathological or experimental systems, it has 
been shown that 4-HNE may also be produced physiologically, 
e.g. as a product from the peroxidation of liver microsomal 
lipids (Benedetti et al., 1979; Benedetti, Comporti and 
Esterbauer, 1980). This raises the possibility hat physiological 
levels of hydroxyalkenals may have a role in normal cell 
metabolism. 
To date, therc is no information in the literature about the 
possible activity of 4-HNE and other hydroxyalkenals in
placenta. The detection of 4-HNE-immunoreactivity n pla- 
centa raises the question whether lipoperoxidation products 
are produced locally in placental cells or represent exogenous 
products that derive from maternal blood flow. Scavenger 
receptor activity has been demonstrated in placental tropho- 
blast cells and macrophages in vitro, thus suggesting that 
placenta may bind also oxidated lipoproteins that circulate in 
maternal blood flow (Malassin6 et al., 1990; Bonet et al., 1995). 
In the case lipoperoxidation products including 4-HNE actu- 
ally derive from maternal circulation, it may be speculated that 
trophoblast cells and mesenchymal cells displaying 4-HNE- 
immunoreactivity may play a protective role with regard to the 
diffusion of lipoperoxidation products from the mother toward 
the embryo. 
However, very low levels of 4-HNE are detectable in plasma 
under physiological condition (Selley et al., 1989) and it has 
been reasoned that significant degree of lipid oxidative modi- 
fication does not take place in plasma because of its high 
antioxidant content (Witzum and Steinberg, 1991). Thus, 
according to current hypothesis about oxidated lipoprotein 
formation (Witzum and Steinberg, 1991), it is presumable that 
lipid oxidative modifications occur mainly in tissue or cell 
microdomains that are sequestered from the man)' plasma 
antioxidants. In line with this view, it may be speculated that 
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4-HNE contained within placental cells is produced locally. 
Accordingly, it has been demonstrated that exogenous per- 
oxide stimulation of isolated placental cotyledons results in 
increased secretion of lipid peroxides, thus suggesting that 
placental cells may be able to produce and release lipo- 
peroxides also in vivo (Walsh and Wang, 1993). 
Normal low density lipoproteins (LDL)  undergo uptake and 
degradation by trophoblastic ells in culture (Winkel et al., 
1980a). Moreover, evidence xists that most of the cholesterol 
used by the placenta for progesterone biosynthesis may derive 
from maternal LDL  (Winkel et al., 1980b). Interestingly, it has 
been observed that LDL  may play a role in the regulation 
of progesterone synthesis and secretion by placental cclls 
(Simpson ct al., 1978). Since trophoblastic cells, that we 
have found to be 4-HNE- immunoreact ivc,  are provided by 
scavenger receptor, it may be hypothesized that LDL  might be 
oxidized by trophoblast cells during blood traversal through 
the intcrvillous space. 
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On the other hand, 4-HNE- immunoreact ive mescnchymal 
cells and endothelial cells, that are localized deep within the 
villus, should lack direct access to circulating lipoprotcins. 
Thus,  4 -HNE contained in villous cells may derive fi'om 
trophoblast cells or may be produced by macrophagcs and 
endothcl ium that are able to produce oxidative modification 
via the lipoxygenase pathway (Sparrow, Parthasarathy and 
Steinberg, 1988; Parthasarathy, Wieland and Stcinbcrg, 1989). 
Interestingly, there is evidence that lipoprotein oxidation 
may be enhanced in pregnancy (Ishihara, 1978; Hubcl ct al., 
1989). Recently it has been hypothesized that a placental 
oxidant-antioxidant imbalance might cause the release of 
l ipopcroxidation products into the circt, lation in pregnancy- 
induced hypertension (Cester et al., 19941, thus suggesting a
role tbr lipoperoxidcs in the pathogchcsis of eclampsia. Further 
study will bc addressed to clarify whcthcr any modification 
of 4-HNE- immunorcact iv i ty  occurs in human prc-cclamptic 
placenta. 
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